MidAmerica Division, Inc. /ID# 222058 — Kansas City, Missouri

MidAmerica Division, Inc. /ID# 222058 is a clinical research site located in Kansas City, Missouri, United States 64132.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

MidAmerica Division, Inc. /ID# 222058 has participated in 1 clinical trials.

Therapeutic areas: Myelofibrosis (MF).

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MidAmerica Division, Inc. /ID# 222058?

MidAmerica Division, Inc. /ID# 222058 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MidAmerica Division, Inc. /ID# 222058 conducted?

MidAmerica Division, Inc. /ID# 222058 has 1 clinical trials on record. Their work covers Myelofibrosis (MF).

Is MidAmerica Division, Inc. /ID# 222058 accredited by Crixeo Health?

MidAmerica Division, Inc. /ID# 222058 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MidAmerica Division, Inc. /ID# 222058?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.